ZA9610073B - Method of using beta-interferons to treat restenosis - Google Patents

Method of using beta-interferons to treat restenosis

Info

Publication number
ZA9610073B
ZA9610073B ZA9610073A ZA9610073A ZA9610073B ZA 9610073 B ZA9610073 B ZA 9610073B ZA 9610073 A ZA9610073 A ZA 9610073A ZA 9610073 A ZA9610073 A ZA 9610073A ZA 9610073 B ZA9610073 B ZA 9610073B
Authority
ZA
South Africa
Prior art keywords
beta
interferons
treat restenosis
treat
restenosis
Prior art date
Application number
ZA9610073A
Other languages
English (en)
Inventor
Anthony Johns
Robert J Mintzer
Original Assignee
Berlex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Lab filed Critical Berlex Lab
Publication of ZA9610073B publication Critical patent/ZA9610073B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9610073A 1995-11-30 1996-11-29 Method of using beta-interferons to treat restenosis ZA9610073B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/565,701 US5681558A (en) 1995-11-30 1995-11-30 Method of using beta-interferons to treat restenosis

Publications (1)

Publication Number Publication Date
ZA9610073B true ZA9610073B (en) 1997-06-18

Family

ID=24259751

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610073A ZA9610073B (en) 1995-11-30 1996-11-29 Method of using beta-interferons to treat restenosis

Country Status (11)

Country Link
US (1) US5681558A (de)
EP (1) EP0869813B1 (de)
JP (2) JP4116075B2 (de)
AT (1) ATE303158T1 (de)
AU (1) AU712960B2 (de)
CA (1) CA2238871C (de)
DE (1) DE69635131T2 (de)
DK (1) DK0869813T3 (de)
ES (1) ES2247607T3 (de)
WO (1) WO1997019697A1 (de)
ZA (1) ZA9610073B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866561A (en) * 1997-08-21 1999-02-02 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
US6537195B2 (en) 2001-05-07 2003-03-25 Xoft, Microtube, Inc. Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia
US7018371B2 (en) * 2001-05-07 2006-03-28 Xoft, Inc. Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
SE462364B (sv) * 1988-09-30 1990-06-18 Goeran Hansson Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos
JPH04116075A (ja) * 1990-09-03 1992-04-16 Hitachi Building Syst Eng & Service Co Ltd エレベータの乗り場報知装置
DE69429087T2 (de) * 1993-01-07 2002-07-11 Thomas Jefferson University, Philadelphia Modulation der proliferation von glatten muskelzellen durch antisense inhibition von c-myc
US6780406B1 (en) * 1994-03-21 2004-08-24 The Regents Of The University Of Michigan Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene
CA2210622A1 (en) * 1995-11-17 1997-05-29 Toray Industries, Inc. An agent protecting endothelial cells

Also Published As

Publication number Publication date
JP2008031179A (ja) 2008-02-14
CA2238871C (en) 2006-08-15
DE69635131T2 (de) 2006-07-06
JP4116075B2 (ja) 2008-07-09
EP0869813A4 (de) 2003-02-05
CA2238871A1 (en) 1997-06-05
AU1070397A (en) 1997-06-19
EP0869813B1 (de) 2005-08-31
ES2247607T3 (es) 2006-03-01
WO1997019697A1 (en) 1997-06-05
DE69635131D1 (de) 2005-10-06
US5681558A (en) 1997-10-28
ATE303158T1 (de) 2005-09-15
JP2000501093A (ja) 2000-02-02
EP0869813A1 (de) 1998-10-14
DK0869813T3 (da) 2006-01-02
AU712960B2 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
HUP9802093A3 (en) Use of nitrogen-monoxyde for producing medicament useful for treatment of vascular thrombosis and restenosis
NZ297320A (en) 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]-benzopyran and medicaments
ZA933994B (en) Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects.
AU131099S (en) A set of bandages
FI921232A7 (fi) Siilorehun entsyymaattinen käsittely
FI973163A7 (fi) Pidätyskyvyttömyyden hoitaminen käyttämällä (S)-oksibutyniiniä ja (S)- desetyylioksibutyniiniä
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
EP0795035A4 (de) Bearbeitung von häuten
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
ZA9610073B (en) Method of using beta-interferons to treat restenosis
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
IL131478A0 (en) Methods for treatment of scar tissue
PT1133296E (pt) Nova aplicacao terapeutica da nicergolina
GR3021171T3 (en) Use of hyaluronic acid and forms to prevent arterial restenosis.
DE59104412D1 (de) Dynamische Redressionsschiene zur Therapie der Vorfussadduktion.
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
GB9317943D0 (en) Treatment of laminitis
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
BA95039A (bs) Set za prevenciju i terapiju bolne menstruacije
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
MX9405923A (es) Mejoras en proceso para humectar y suavizar la piel.
MX9706825A (es) El uso farmacologico de ciertos derivados de cistina.
IT1275604B1 (it) Dispositivo per la riduzione di stenosi di organi del corpo umano